Diseases, Conditions, Syndromes

US to start vaccinating as Germany returns to partial lockdown

The United States prepared to start its COVID-19 vaccination program on Monday as the nation's death toll edged towards 300,000, while Germany announced a partial lockdown over the holidays due to an explosion of cases.

Vaccination

US experts convene to decide whether to OK Pfizer vaccine

A U.S. government advisory panel convened on Thursday to decide whether to endorse large-scale use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans.

Diseases, Conditions, Syndromes

Biden's health team offers glimpse of his COVID-19 strategy

President-elect Joe Biden's choices for his health care team point to a stronger federal role in the nation's COVID-19 strategy, restoration of a guiding stress on science and an emphasis on equitable distribution of vaccines ...

Diseases, Conditions, Syndromes

Health officials warn Americans not to let their guard down

With a COVID-19 vaccine perhaps just days away in the U.S., most of California headed into another lockdown Sunday because of the surging outbreak and top health officials warned Americans that this is no time to let their ...

Diseases, Conditions, Syndromes

Bleak Covid winter: America's outbreak enters worst phase

The first vaccines are only weeks away but the winter is looking bleak for the United States, where the coronavirus outbreak is worse than ever and 150,000 more people could perish by February.

Diseases, Conditions, Syndromes

US scientists developing nasal spray to prevent COVID-19

Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.

page 12 from 40